Illumina exhibits better profitability ratios than many of its peers, which indicates that the company could continue to invest in its operations. In Q3 2025, ILMN raised its EPS to $4.65-$4.75, ...
With Illumina's divestiture of GRAIL, the company will improve its operating expenses, since GRAIL reported significant losses while it was part of Illumina. The global DNA sequencing market is ...
LITTLE ROCK — Helicos Biosciences Corp.'s gene-sequencing machine mapped the genome of a Stanford University professor, who developed the technology, for less than $50,000 using the labor of just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback